Financials Evotec SE

Equities

EVT

DE0005664809

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 09:08:29 09/07/2025 pm IST			After hours 09:57:51 pm
7.106 ^EUR	-2.26%		7.114	+0.11%

02:34pm	EVOTEC : Deutsche Bank reiterates its Neutral rating	ZD
26/06	EVOTEC : Warburg Research remains its Buy rating	ZD

Projected Income Statement: Evotec SE

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	500.9	618	751.4	781.4	797	851.3	937.4	1,046
Change	-	23.38%	21.59%	3.99%	1.99%	6.82%	10.11%	11.64%
EBITDA ¹	106.6	107.3	101.7	66.35	22.56	40.22	102.9	170.3
Change	-	0.64%	-5.26%	-34.73%	-65.99%	78.27%	155.88%	65.47%
EBIT ¹	48.52	41	20.85	-26.63	-142.5	-64.47	-10.67	70.16
Change	-	-15.51%	-49.14%	-227.71%	-435.25%	54.77%	83.45%	757.45%
Interest Paid ¹	-8.465	-6.982	-13.15	-2.476	-9.264	-10.81	-10.62	-10.52
Earnings before Tax (EBT) ¹	25.81	237	-154	-80.59	-194	-100.6	-38.64	33.14
Change	-	818.28%	-164.97%	47.65%	-140.69%	48.15%	61.58%	185.78%
Net income ¹	6.252	215.5	-175.7	-83.91	-196.1	-81.32	-30.26	31.75
Change	-	3,347.06%	-181.51%	52.23%	-133.67%	58.53%	62.79%	204.95%
Announcement Date	25/03/21	12/04/22	12/05/23	24/04/24	17/04/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020 Q2	2020 Q3	2020 Q4	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	111.6	129.4	140.5	-	159.7	187.1	164.7	172.2	173.9	240.7	170.3	196.3	250.1	208.7	182.1	184.9	221.2	200	204.6	209.6	235.9	249.5	230.5	233.2	248
Change	-	15.99%	8.56%	-	-	17.17%	-11.97%	4.57%	0.98%	38.42%	-29.25%	15.27%	27.4%	-16.53%	-12.75%	1.52%	19.65%	-9.61%	2.3%	2.48%	12.52%	5.76%	-7.62%	1.17%	6.35%
EBITDA ¹	17.27	29.67	29.68	-	-	37.21	18.9	14.7	10.96	57.05	-	24.11	16.14	7.815	-8.282	-5.504	28.54	3.107	8.887	9.793	18.13	-	-	-	-
Change	-	71.86%	0.02%	-	-	-	-49.21%	-22.22%	-25.41%	420.38%	-	-	-33.06%	-51.58%	-205.98%	33.54%	618.44%	-89.11%	186.02%	10.21%	85.09%	-	-	-	-
EBIT ¹	2.822	16.37	13.24	-	-	14.94	0.463	-3.77	-13.53	37.69	-36.29	-12.19	-7.687	-14.74	-36.15	-26.49	6.784	-	-18.79	-18.12	-10.02	-	-	-	-
Change	-	480.05%	-19.13%	-	-	-	-96.9%	-914.25%	-258.86%	378.56%	-196.29%	66.42%	36.92%	-91.73%	-145.28%	26.71%	125.61%	-	-	3.58%	44.68%	-	-	-	-
Charge d'intérêts ¹	-2.639	-	-	-	-	-2.421	-	-3.667	0.05	-2.278	0.286	-1.039	-	-1.255	-2.743	-1.866	-4.784	-	-2.481	-2.481	-2.481	-	-	-	-
Earnings before Tax (EBT) ¹	-	-	6.461	-	-	-17.84	-	-24.34	-43.36	-17.52	-20.44	-29.92	-24.02	-26.78	-104.5	-46.87	-15.87	-	-13.73	-12.46	-12.51	-	-	-	-
Change	-	-	-	-	-	-	-	-	-78.19%	59.59%	-16.62%	-46.38%	19.69%	-11.48%	-290.02%	55.13%	66.15%	-	-	9.21%	-0.4%	-	-	-	-
Net income ¹	-9.817	-1.41	0.403	60.02	-	-31.48	-73.24	-27.94	-47.28	-27.2	-14.93	-38.96	-16.13	-20.67	-94.93	-39.63	-40.84	-31.58	-22.7	-22.03	-13.93	-	-	-	-
Change	-	85.64%	128.58%	14,792.06%	-	-	-132.68%	61.86%	-69.22%	42.46%	45.12%	-160.94%	58.59%	-28.16%	-359.21%	58.25%	-3.04%	22.68%	28.1%	2.98%	36.76%	-	-	-	-
Announcement Date	12/08/20	12/11/20	25/03/21	11/08/21	12/11/21	12/04/22	11/05/22	11/08/22	09/11/22	12/05/23	29/08/23	08/11/23	24/04/24	22/05/24	14/08/24	06/11/24	17/04/25	06/05/25	-	-	-	-	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2022 S1	2023 S1	2024 S1
Net sales ¹	336.9	383.8	390.8
Change	-	13.94%	1.83%
EBITDA ¹	33.64	26.1	-0.467
Change	-	-22.41%	-101.79%
EBIT	-3.307	-	-
Change	-	-	-
Charge d'intérêts	-	-	-
Earnings before Tax (EBT)	-	-	-
Change	-	-	-
Net income	-101.2	-28.83	-
Change	-	71.51%	-
Announcement Date	11/08/22	29/08/23	14/08/24

¹EUR in Million

Estimates

Forecast Balance Sheet: Evotec SE

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-0.67	-345	-212	22.1	216	165	201	163
Change	-	-51,392.54%	38.55%	110.42%	877.38%	-23.6%	21.82%	-18.91%
Announcement Date	25/03/21	12/04/22	12/05/23	24/04/24	17/04/25	-	-	-

¹EUR in Million

Estimates

Cash Flow Forecast: Evotec SE

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	99.07	118.9	181.4	213.3	117.5	105.6	105.9	110.2
Change	-	20.06%	52.47%	17.63%	-44.93%	-10.06%	0.22%	4.1%
Free Cash Flow (FCF) ¹	-54.35	3.294	21.75	-176.9	-99.25	-68.5	-8.5	74
Change	-	106.06%	560.35%	-913.18%	43.89%	30.98%	87.59%	970.59%
Announcement Date	25/03/21	12/04/22	12/05/23	24/04/24	17/04/25	-	-	-

¹EUR in Million

Estimates

Forecast Financial Ratios: Evotec SE

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	21.28%	17.36%	13.53%	8.49%	2.83%	4.72%	10.98%	16.28%
EBIT Margin (%)	9.69%	6.63%	2.77%	-3.41%	-17.88%	-7.57%	-1.14%	6.7%
EBT Margin (%)	5.15%	38.34%	-20.49%	-10.31%	-24.34%	-11.81%	-4.12%	3.17%
Net margin (%)	1.25%	34.87%	-23.38%	-10.74%	-24.6%	-9.55%	-3.23%	3.03%
FCF margin (%)	-10.85%	0.53%	2.89%	-22.64%	-12.45%	-8.05%	-0.91%	7.07%
FCF / Net Income (%)	-869.34%	1.53%	-12.38%	210.79%	50.62%	84.24%	28.09%	233.04%
Profitability
ROA	0.47%	11.66%	-7.82%	-2.8%	-6.78%	-4.73%	-1.95%	0.06%
ROE	1.04%	20.5%	-13.7%	-5.46%	-6.08%	-8.85%	-3.21%	1.14%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	0.33x	9.57x	4.11x	1.95x	0.96x
Debt / Free cash flow	-	-	-	-0.12x	-2.18x	-2.41x	-23.65x	2.2x
Capital Intensity
CAPEX / Current Assets (%)	19.78%	19.25%	24.13%	27.3%	14.74%	12.41%	11.3%	10.53%
CAPEX / EBITDA (%)	92.92%	110.85%	178.4%	321.5%	520.6%	262.64%	102.87%	64.71%
CAPEX / FCF (%)	-182.28%	3,610.9%	833.73%	-120.6%	-118.36%	-154.23%	-1,245.65%	148.94%
Items per share
Cash flow per share ¹	0.2887	0.7346	1.15	0.206	1.028	0.1584	0.4886	0.7859
Change	-	154.49%	56.49%	-82.08%	398.83%	-84.59%	208.5%	60.85%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	4.417	7.812	6.718	6.32	1.189	4.911	4.735	4.774
Change	-	76.88%	-14%	-5.92%	-81.19%	312.94%	-3.59%	0.83%
EPS ¹	0.04	1.3	-0.99	-0.47	-1.11	-0.4603	-0.1828	0.1092
Change	-	3,150%	-176.15%	52.53%	-136.17%	58.53%	60.3%	159.78%
Nbr of stocks (in thousands)	1,63,476	1,75,162	1,76,703	1,76,936	1,77,303	1,77,603	1,77,603	1,77,603
Announcement Date	25/03/21	12/04/22	12/05/23	24/04/24	17/04/25	-	-	-